Loading...

Skip Navigation LinksHome > Support Groups > Discussion Messages
Miscellaneous :
General

This support group serves as an information center for other discussions on health topics.

 

Join this Group


 











Loading...

News Comments
Add a topic Recent discussions
Start watching this topic
Rivaroxaban Plus Standard Antiplatelet Therapy Improves Survival After Myocardial Infarction

A new study published in the New England Journal of Medicine reveals that the oral anticoagulant rivaroxaban improves survival rates after a myocardial infarction when given in combination standard antiplatelet therapy

More than 15,500 ...Read More

Posted on : Tuesday, November 15, 2011 8:08 PM
Add reply       No of replies : 0

Report Abuse

You can help us in removing abusive content or spam.
Your Name
Your Email ID
Subject
Message
(Maximum 3000 Characters)
  


Member Sign In

Remember me
Forgot Password?
Sign up now


Medwonders has 257232 Members and 444 Groups.
Last Updated - Nov 24, 2024 - Designed & Content Managed by Medindia4u.com Pvt. Ltd.
Copyright © 2024 Medindia4u.com Pvt. Ltd. All rights reserved.